Merck KGaA - Product Pipeline Review - 2016

  • ID: 3674246
  • Company Profile
  • 123 pages
  • Global Markets Direct
  • Merck Group
1 of 4
Merck KGaA - Product Pipeline Review - 2016

Summary

‘Merck KGaA - Product Pipeline Review - 2016’, provides an overview of the Merck KGaA’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Merck KGaA, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Merck KGaA
- The report provides overview of Merck KGaA including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Merck KGaA’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Merck KGaA’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Merck KGaA’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Merck KGaA
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Merck KGaA’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Merck KGaA Snapshot

Merck KGaA Overview

Key Information

Key Facts

Merck KGaA - Research and Development Overview

Key Therapeutic Areas

Merck KGaA - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Combination Treatment Modalities

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Merck KGaA - Pipeline Products Glance

Merck KGaA - Late Stage Pipeline Products

Filing rejected/Withdrawn Products/Combination Treatment Modalities

Phase III Products/Combination Treatment Modalities

Merck KGaA - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Merck KGaA - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Merck KGaA - Drug Profiles

cetuximab

Product Description

Mechanism of Action

R&D Progress

avelumab

Product Description

Mechanism of Action

R&D Progress

choriogonadotropin alfa

Product Description

Mechanism of Action

R&D Progress

cladribine

Product Description

Mechanism of Action

R&D Progress

atacicept

Product Description

Mechanism of Action

R&D Progress

M-2736

Product Description

Mechanism of Action

R&D Progress

pimasertib hydrochloride

Product Description

Mechanism of Action

R&D Progress

sprifermin

Product Description

Mechanism of Action

R&D Progress

tecemotide

Product Description

Mechanism of Action

R&D Progress

tepotinib

Product Description

Mechanism of Action

R&D Progress

BGB-283

Product Description

Mechanism of Action

R&D Progress

BGB-290

Product Description

Mechanism of Action

R&D Progress

DI-B4

Product Description

Mechanism of Action

R&D Progress

L-Praziquantel

Product Description

Mechanism of Action

R&D Progress

M-1095

Product Description

Mechanism of Action

R&D Progress

M-2698

Product Description

Mechanism of Action

R&D Progress

M-2951

Product Description

Mechanism of Action

R&D Progress

M-3814

Product Description

Mechanism of Action

R&D Progress

M-7824

Product Description

Mechanism of Action

R&D Progress

M-9241

Product Description

Mechanism of Action

R&D Progress

MSC-2015103B

Product Description

Mechanism of Action

R&D Progress

pimasertib hydrochloride + voxtalisib

Product Description

Mechanism of Action

R&D Progress

rimeporide

Product Description

Mechanism of Action

R&D Progress

ALX-0751

Product Description

Mechanism of Action

R&D Progress

AS-605240

Product Description

Mechanism of Action

R&D Progress

cilengitide

Product Description

Mechanism of Action

R&D Progress

DDD-498

Product Description

Mechanism of Action

R&D Progress

M-7583

Product Description

Mechanism of Action

R&D Progress

Monoclonal Antibody Conjugates for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit Aurora B Kinase for Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Inhibit CDK8 for Colorectal Carcinoma

Product Description

Mechanism of Action

R&D Progress

Vaccine 1 for Cancer

Product Description

Mechanism of Action

R&D Progress

Vaccine 2 for Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit SYK for Inflammation

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit WNT Pathway for Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Autoimmune Disorder and Oncology

Product Description

Mechanism of Action

R&D Progress

Small Molecules for Multiple Sclerosis

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Agonize TNFR for Cancer

Product Description

Mechanism of Action

R&D Progress

Merck KGaA - Pipeline Analysis

Merck KGaA - Pipeline Products by Target

Merck KGaA - Pipeline Products by Route of Administration

Merck KGaA - Pipeline Products by Molecule Type

Merck KGaA - Pipeline Products by Mechanism of Action

Merck KGaA - Recent Pipeline Updates

Merck KGaA - Dormant Projects

Merck KGaA - Discontinued Pipeline Products

Discontinued Pipeline Product Profiles

abituzumab

anastrozole

atacicept

cilengitide

cladribine

Drug to Antagonize Oxytocin Receptor for Pre-term Labor

EMD-1204831

emfilermin

EML-4156

M-1095

matuzumab

MSB-0010445

onercept

Osteopontin

pimasertib hydrochloride

plovamer acetate

sarizotan hydrochloride

tecemotide

tucotuzumab celmoleukin

Merck KGaA - Company Statement

Merck KGaA - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Merck KGaA, Key Information

Merck KGaA, Key Facts

Merck KGaA - Pipeline by Indication, 2016

Merck KGaA - Pipeline by Stage of Development, 2016

Merck KGaA - Monotherapy Products in Pipeline, 2016

Merck KGaA - Combination Treatment Modalities in Pipeline, 2016

Merck KGaA - Partnered Products in Pipeline, 2016

Merck KGaA - Partnered Products/ Combination Treatment Modalities, 2016

Merck KGaA - Out-Licensed Products in Pipeline, 2016

Merck KGaA - Out-Licensed Products/ Combination Treatment Modalities, 2016

Merck KGaA - Filing rejected/Withdrawn, 2016

Merck KGaA - Phase III, 2016

Merck KGaA - Phase II, 2016

Merck KGaA - Phase I, 2016

Merck KGaA - Preclinical, 2016

Merck KGaA - Discovery, 2016

Merck KGaA - Pipeline by Target, 2016

Merck KGaA - Pipeline by Route of Administration, 2016

Merck KGaA - Pipeline by Molecule Type, 2016

Merck KGaA - Pipeline Products by Mechanism of Action, 2016

Merck KGaA - Recent Pipeline Updates, 2016

Merck KGaA - Dormant Developmental Projects,2016

Merck KGaA - Discontinued Pipeline Products, 2016

Merck KGaA, Subsidiaries

List of Figures

Merck KGaA - Pipeline by Top 10 Indication, 2016

Merck KGaA - Pipeline by Stage of Development, 2016

Merck KGaA - Monotherapy Products in Pipeline, 2016

Merck KGaA - Partnered Products in Pipeline, 2016

Merck KGaA - Out-Licensed Products in Pipeline, 2016

Merck KGaA - Pipeline by Top 10 Target, 2016

Merck KGaA - Pipeline by Route of Administration, 2016

Merck KGaA - Pipeline by Molecule Type, 2016

Merck KGaA - Pipeline Products by Top 10 Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll